On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

WHRN

whirlin

Chromosome 9q32 Various HGNC:16361 Tier C
WHRN 9q32 p arm q arm 9

WHRN is located on the long (q) arm of chromosome 9, at band 9q32. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 9 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

WHRN encodes whirlin, a scaffolding protein that plays a fundamental role in assembling and maintaining protein complexes within sensory cells of the inner ear and retina. These complexes are essential for converting mechanical or light stimuli into electrical signals that the nervous system can interpret. The gene is located on chromosome 9 and produces a protein comprising 907 amino acids. Variants in WHRN are associated with forms of hereditary hearing loss and retinal disorders, both arising from defects in sensory cell structure and function. The protein's scaffolding activity depends on specialised modular domains that bind to partner proteins, positioning them correctly within the cell.

What the gene does

Whirlin functions as a molecular scaffold, organising protein networks that maintain the structural architecture of stereocilia - hair-like projections extending from sensory hair cells in the cochlea. These stereocilia must be precisely arranged in graduated bundles to detect sound vibrations effectively. Whirlin anchors proteins at specific points along the stereocilia, ensuring they remain properly aligned and mechanically coupled. In photoreceptor cells of the retina, whirlin contributes to the organisation of the connecting cilium, a narrow bridge linking the light-sensing outer segment to the cell body. This cilium acts as a conduit for proteins and molecules essential for phototransduction, the process of converting light into neural signals. Without functional whirlin, both stereocilia bundles and photoreceptor cilia become disorganised, impairing sensory signal transduction. The protein achieves these scaffolding roles through direct interactions with multiple binding partners, forming stable complexes that provide mechanical support and coordinate cellular responses to sensory input.

Video: Genetics 101

Chromosome location

WHRN is located on the long arm of chromosome 9 at position 9q32. This chromosomal region contains multiple genes involved in sensory and developmental processes. The gene spans a substantial genomic interval and is transcribed into messenger RNA that undergoes alternative splicing, generating different whirlin isoforms with varying domain compositions. These isoforms may have distinct roles in different cell types or developmental stages.

Protein structure

The whirlin protein contains three PDZ domains that mediate protein-protein interactions. PDZ 1 spans amino acids 140-223, PDZ 2 extends from amino acids 279-361, and PDZ 3 occupies amino acids 816-899 near the C-terminus. PDZ domains are modular interaction units commonly found in scaffolding proteins, recognising specific amino acid sequences at the ends of target proteins. The whirlin PDZ domains bind to distinct sets of partner proteins, enabling the assembly of multi-component complexes. Between and flanking these structured domains are several disordered regions (amino acids 243-264, 502-540, 565-663, 684-717, and 742-815). Intrinsically disordered regions often provide flexibility, allowing the protein to adapt its shape when engaging multiple binding partners simultaneously or coordinating dynamic cellular processes. This domain architecture positions whirlin as a versatile organiser capable of bringing together diverse proteins into functional assemblies within sensory cells.

Domain map · 907 amino acids
PDZ 1 (140-223)PDZ 2 (279-361)PDZ 3 (816-899)PDZ 1140-223PDZ 2279-361PDZ 3816-8991~454907
Domain - independent functional unit
🧬 Explore 3D structure on AlphaFold
UniProt:Q9P202Length:907 aaStructure:AlphaFold

Key variants

Pathogenic variants in WHRN disrupt the protein's scaffolding function, typically through loss-of-function mechanisms such as premature stop codons, frameshifts, or missense changes that impair PDZ domain binding activity. The inheritance pattern associated with WHRN-related conditions can vary, with both autosomal recessive and digenic inheritance reported in different families. The severity and age of onset of hearing loss or retinal disease may depend on which protein isoforms are affected and the residual scaffolding capacity of the altered whirlin protein.

No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.

Associated conditions

Variants in WHRN are primarily associated with syndromic and non-syndromic forms of congenital hearing loss. Some individuals with WHRN variants experience isolated profound deafness from birth, while others develop a combination of hearing impairment and progressive retinal degeneration, a presentation sometimes classified within the Usher syndrome spectrum. Retinal involvement typically manifests as retinitis pigmentosa, characterised by night blindness and progressive loss of peripheral vision. The dual sensory deficits reflect the shared dependence of cochlear hair cells and retinal photoreceptors on whirlin's scaffolding activity. The severity of symptoms can vary considerably, influenced by the specific variants inherited and possible modifier genes.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

UK clinical status

WHRN is included on two NHS Genomic Medicine Service panels. It appears on the Monogenic hearing loss panel (rated green, version R67), indicating strong evidence for its role in inherited deafness and relevance for diagnostic genomic testing in patients with unexplained hearing impairment. The gene is also listed on the Retinal disorders panel (rated green, version R32), reflecting its association with inherited retinal disease. Green classification denotes high confidence in the gene-disease relationship, meaning WHRN variants identified in clinical testing are considered diagnostically significant when consistent with the patient's phenotype.

Frequently asked questions

What types of hearing loss are associated with WHRN variants?

WHRN variants typically cause congenital sensorineural hearing loss, meaning the impairment arises from defects in the inner ear's sensory cells rather than structural abnormalities of the outer or middle ear. Severity ranges from profound deafness present from birth to progressive hearing impairment, and some individuals also develop retinal disease.

How does whirlin contribute to vision?

Whirlin helps organise the connecting cilium in retinal photoreceptors, a structure that transports essential proteins between different cellular compartments. When whirlin is absent or dysfunctional, this transport system fails, leading to photoreceptor degeneration and progressive vision loss characteristic of retinitis pigmentosa.

Can WHRN-related hearing loss be treated?

While there is currently no cure for genetic hearing loss caused by WHRN variants, cochlear implants can provide substantial benefit for individuals with profound deafness by directly stimulating auditory nerve fibres. Early diagnosis and intervention are important for supporting language development in children with congenital hearing impairment.

Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 17 April 2026. Content compiled from HGNC · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .